Francesca Veneziani

446 total citations
27 papers, 307 citations indexed

About

Francesca Veneziani is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Francesca Veneziani has authored 27 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 12 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Infectious Diseases. Recurrent topics in Francesca Veneziani's work include Acute Myocardial Infarction Research (13 papers), Cardiac Imaging and Diagnostics (12 papers) and COVID-19 Clinical Research Studies (6 papers). Francesca Veneziani is often cited by papers focused on Acute Myocardial Infarction Research (13 papers), Cardiac Imaging and Diagnostics (12 papers) and COVID-19 Clinical Research Studies (6 papers). Francesca Veneziani collaborates with scholars based in Italy, Poland and Netherlands. Francesca Veneziani's co-authors include María Infantino, Valentina Grossi, Patrizia Casprini, Mariangela Manfredi, Maurizio Benucci, Barbara Lari, Piero Cappelletti, Giovanni Ciotta, Cristina Taddei and Sergio Fabbri and has published in prestigious journals such as Scientific Reports, PLoS Pathogens and Journal of Medical Virology.

In The Last Decade

Francesca Veneziani

21 papers receiving 284 citations

Peers

Countries citing papers authored by Francesca Veneziani

Since Specialization

Citations

This map shows the geographic impact of Francesca Veneziani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Veneziani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Veneziani more than expected).

Fields of papers citing papers by Francesca Veneziani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Veneziani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Veneziani. The network helps show where Francesca Veneziani may publish in the future.

Co-authorship network of co-authors of Francesca Veneziani

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Veneziani. A scholar is included among the top collaborators of Francesca Veneziani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Veneziani. Francesca Veneziani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolomic and lipoproteomic differences and similarities between COVID-19 and other types of pneumonia 2025 ·Scientific Reports ·Veronica Ghini, (unknown), (unknown), (unknown), Laura Bertini, Francesca Veneziani, Vieri Vannucchi, Paola Turano	1
2	Il punto sul controllo di qualità di troponina (cTn) per esami in Point-of-Care Testing 2024 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·(unknown), (unknown), Francesca Veneziani, Elisabetta Stenner, Piero Cappelletti	0
3	Sono necessari 99° percentili di troponina ad alta sensibilità (hs-cTn) specifici per etnia, età e sesso? Parte I: Il peso dell'etnia e dell'età 2024 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·(unknown), (unknown), Piero Cappelletti, (unknown), (unknown), (unknown), Marco Moretti, (unknown), Elisabetta Stenner, (unknown), Francesca Veneziani, Martina Di Pietro, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), G. Galli	0
4	Raccomandazione del GdS-MM SIPMeL sul turnaround time per la troponina: aggiornamento 2024 2024 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·(unknown), (unknown), Piero Cappelletti, (unknown), (unknown), Elisabetta Stenner, (unknown), (unknown), Marco Moretti, (unknown), Francesca Veneziani, (unknown), (unknown), (unknown), Martina Di Pietro, (unknown), (unknown), (unknown), (unknown), G. Galli	0
5	Point-of-care testing di troponina ad alta sensibilità (hs-cTn POCT): stato dell'arte e prospettive 2023 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·(unknown), Piero Cappelletti, Marco Moretti, (unknown), Elisabetta Stenner, (unknown), Francesca Veneziani, (unknown), Martina Di Pietro, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Matteo Cassin, G. Galli	2
6	Delirium and IL-6 added to clinical scores improves their performance: a prospective analysis of CALL, PREDI-CO, MRS score applied to a population of patients admitted to internal medicine ward 2023 ·Internal and Emergency Medicine ·Vieri Vannucchi, Lorenzo Pelagatti, (unknown), L Bertini, (unknown), (unknown), Francesca Veneziani, (unknown), Giancarlo Landini	0
7	Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients 2022 ·PLoS Pathogens ·Veronica Ghini, Gaia Meoni, Lorenzo Pelagatti, (unknown), Francesca Veneziani, (unknown), Vieri Vannucchi, Laura Bertini, Claudio Luchinat, Giancarlo Landini, Paola Turano	35
8	Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience 2022 ·Clinical Immunology ·María Infantino, (unknown), Massimo Antonio Di Pietro, (unknown), (unknown), (unknown), (unknown), (unknown), Marta Tilli, Valentina Grossi, Barbara Lari, (unknown), (unknown), (unknown), Alessandra Cartocci, Maurizio Benucci, Francesca Veneziani, Patrizia Casprini, Mariangela Manfredi	4
9	Raccomandazioni del GdS MM SIPMeL per l'uso dei biomarcatori cardiaci nella diagnostica di NSTEMI. Parte prima: cosa dicono le linee guida 2021 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·(unknown), Piero Cappelletti, (unknown), Elisabetta Stenner, Marco Moretti, Francesca Veneziani, (unknown), (unknown), Matteo Cassin, (unknown), (unknown), Martina Di Pietro, (unknown), (unknown), (unknown), (unknown), G. Galli	7
10	Raccomandazioni del GdS MM SIPMeL per l'uso dei biomarcatori cardiaci in NSTEMI. Parte seconda: evidenze nella diagnosi 2021 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·(unknown), Piero Cappelletti, Marco Moretti, Francesca Veneziani, (unknown), (unknown), (unknown), Matteo Cassin, Elisabetta Stenner, (unknown), (unknown), Martina Di Pietro, (unknown), (unknown), (unknown), (unknown), G. Galli	6
11	Gli algoritmi rapidi per NSTEMI tra necessità cliniche e criticità diagnostiche 2021 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·Marco Moretti, (unknown), Piero Cappelletti, (unknown), (unknown), Elisabetta Stenner, Francesca Veneziani, (unknown), (unknown), (unknown), Martina Di Pietro, (unknown), (unknown), (unknown), (unknown), Matteo Cassin, G. Galli	2
12	Raccomandazioni del GdS MM SIPMeL per l'uso dei marcatori miocardiaci nella diagnostica di NSTEMI. Parte terza: prognosi e stratificazione del rischio 2021 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·(unknown), Piero Cappelletti, (unknown), Martina Di Pietro, Marco Moretti, Francesca Veneziani, (unknown), Elisabetta Stenner, (unknown), Matteo Cassin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), G. Galli	2
13	Vantaggi, limiti e prospettive dei test sierologici nell'infezione da SARS-CoV-2 (COVID-19) 2020 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·María Infantino, Arianna Damiani, Francesca Li Gobbi, Valentina Grossi, Barbara Lari, Donatella Macchia, Patrizia Casprini, Francesca Veneziani, Danilo Villalta, Nicola Bizzaro, Piero Cappelletti, Martina Fabris, Luca Quartuccio, Maurizio Benucci, Mariangela Manfredi	1
14	Diagnostic accuracy of an automated chemiluminescent immunoassay for anti‐SARS‐CoV‐2 IgM and IgG antibodies: an Italian experience 2020 ·Journal of Medical Virology ·María Infantino, Valentina Grossi, Barbara Lari, (unknown), Alessandro Perri, (unknown), (unknown), (unknown), Giovanni Ciotta, Cristina Taddei, Maurizio Benucci, Patrizia Casprini, Francesca Veneziani, Sergio Fabbri, (unknown), Mariangela Manfredi	106
15	Il problema dei falsi positivi e falsi negativi di troponina. Parte III: il ruolo dell'industria biomedica 2019 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·Francesca Veneziani, (unknown), (unknown), Marco Moretti, (unknown), G. Galli, (unknown), Elisabetta Stenner, (unknown), (unknown), (unknown), (unknown), Matteo Cassin, (unknown), Piero Cappelletti	1
16	Il problema dei falsi positivi e falsi negativi di troponina. Parte II: dati e riflessioni dalla IV indagine del GdS MM SIPMeL 2019 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·Francesca Veneziani, G. Galli, (unknown), Marco Moretti, (unknown), (unknown), (unknown), Elisabetta Stenner, (unknown), (unknown), (unknown), (unknown), Matteo Cassin, (unknown), Piero Cappelletti	2
17	Il problema dei falsi positivi e falsi negativi di troponina. Parte IV: Raccomandazioni del Gruppo di Studio sui Marcatori Miocardici (GdS MM) SIPMeL 2019 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·Francesca Veneziani, Marco Moretti, Elisabetta Stenner, (unknown), (unknown), G. Galli, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Matteo Cassin, (unknown), Piero Cappelletti	2
18	Il problema dei falsi positivi e falsi negativi di troponina. Parte I: revisione critica della letteratura 2019 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·Francesca Veneziani, (unknown), Elisabetta Stenner, Marco Moretti, (unknown), G. Galli, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Matteo Cassin, (unknown), Piero Cappelletti	4
19	Il tempo di risposta del Laboratorio (turnaround time, TAT) per la troponina (cTn). Raccomandazione del GdS MM SIPMeL 2018 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·(unknown), Matteo Cassin, (unknown), Piero Cappelletti, Francesca Veneziani, (unknown), (unknown), Elisabetta Stenner, Marco Moretti, (unknown), (unknown), (unknown), (unknown), (unknown), G. Galli	7
20	La IV indagine del GdS MM SIPMeL: i marcatori miocardici di “necrosi” in Italia 2018 ·La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine ·G. Galli, (unknown), Marco Moretti, (unknown), Francesca Veneziani, (unknown), (unknown), Elisabetta Stenner, (unknown), (unknown), (unknown), (unknown), Matteo Cassin, (unknown), Valentino Miconi, Piero Cappelletti	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact